Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
491 studies found for:    "Nasopharyngeal carcinoma"
Show Display Options
Rank Status Study
1 Completed Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli
Condition: Nasopharyngeal Carcinoma
Intervention:
2 Not yet recruiting Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Donafenib
3 Unknown  Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Drug: Gemcitabine and cisplatin;   Drug: Cisplatin
4 Active, not recruiting Nasopharyngeal Carcinoma Post IMRT
Condition: Nasopharyngeal Carcinoma
Intervention:
5 Completed HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Procedure: interventional therapy
6 Completed Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: 5-fluorouracil (5-FU)
7 Recruiting TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Other: Drug: Taxol,cisplatin and capecitabine;   Other: Drug: Cisplatin and 5-Fluorouracil
8 Recruiting The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Gemcitabine;   Drug: cisplatin;   Radiation: Intensity-modulated Radiotherapy
9 Terminated SOX as Salvage Treatment in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: S-1 plus oxaliplatin
10 Completed Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Biological: DNAzyme targeting EBV-LMP1 (DZ1);   Other: Saline
11 Recruiting Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Apatinib mesylate tablet
12 Recruiting The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Celecoxib;   Drug: Nedaplatin;   Radiation: Concurrent Radiotherapy
13 Not yet recruiting Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients
Condition: Nasopharyngeal Carcinoma
Interventions: Dietary Supplement: Sodium nitrate;   Dietary Supplement: sodium chloride
14 Unknown  Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: endostatin
15 Unknown  Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients
Condition: Nasopharyngeal Carcinoma
Interventions: Dietary Supplement: nitrate supplementation;   Dietary Supplement: Placebo
16 Recruiting Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Diagnostic Test: Plasma EBV DNA
17 Recruiting Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Capecitabine
18 Not yet recruiting IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: Intensity modulated radiotherapy;   Drug: Cisplatin
19 Recruiting Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: capecitabine;   Other: Best supportive care (BSC)
20 Not yet recruiting Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Endostar;   Drug: DDP

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.